ÂÜÀòÂÒÂ×

Colleen comes from a multidisciplinary background training in immunology with a particular focus on the intersection of autoimmunity and infectious disease. Her graduate work at the University of Chicago has led to better understanding of how polyreactive antibodies are created. In her postdoctoral research at The Scripps Research Institute, Colleen built tools and laid the groundwork for creating HIV vaccine strategies that elicit broadly neutralizing antibodies. As a Principal Scientist at Celdara Medical, Colleen has been responsible for transitioning multiple assets from academic discovery through early proof-of-concept. At Aclys, Colleen designed and helped build a mammalian cell-based antibody engineering platform that has proven to be both high speed and high quality. In addition to these roles, Colleen is a member of the Scientific Advisory Board at PanSec. In her spare time, Colleen enjoys horseback riding, spending time with her family, and watching Hallmark Christmas movies.